Continued Increase of Erythromycin- and Clindamycin-Nonsusceptibility among Invasive Group A Streptococci Driven by Genomic Clusters, USA, 2018-2019.
Yuan LiJoy RiversSaundra MathisZhongya LiLesley McGeeSopio ChochuaBenjamin J MetcalfKatherine E Fleming-DutraSrinivas A NanduriBernard BeallPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
We analyzed 9630 invasive Group A Streptococci (iGAS) surveillance isolates in the USA. From 2015-2017 to 2018-2019, significant increases in erythromycin-nonsusceptibility (18% vs. 25%) and clindamycin-nonsusceptibility (17% vs. 24%) occurred, driven mainly by rapid expansions of genomic subclones. Prevention and control of clustered infections appear key to containing antimicrobial resistance.